HIGHLIGHTS
SUMMARY
Worldwide, an estimated 19.3 million new cases of cancer were diagnosed in 2020, with an expected increase to 28.4 million in 2040, and around one-half of all these patients will receive radiation therapy (RT) at some point in their illness. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and ISPOR suggestions for the critical appraisal of systematic reviews with costs and cost-effectiveness outcomes were followed to conduct this systematic review. Model-based and empirical health economic studies, and full and partial economic evaluations comparing MRIgRT with other . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.